Recruiting OBSERVATIONAL NCT05859659

Clinical, patHOlogical and Imaging Project of nEuro-oncology (HOPE)

Sponsor: Yaou Liu

Conditions Brain (Nervous System) Cancers Brain Tumor Glioma

Interventions This study does not intervene in this process.

Updated 5 times since 2023 Last updated: Mar 5, 2026 Started: Jan 1, 2022 Primary completion: Dec 31, 2030 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05859659, this observational or N/A phase trial focuses on Brain (Nervous System) Cancers and Brain Tumor and remains actively recruiting participants. Sponsored by Yaou Liu, it has been updated 5 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Mar 2026 — Present [monthly]

Recruiting

Status: Unknown → Recruiting
Jun 2025 — Mar 2026 [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Jun 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Jun 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yaou Liu

Data source: Beijing Tiantan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China